Lauren Santye, Assistant Editor

Gene therapy stimulates blood vessel growth in the heart to avoid cancer drug side effects.

Ingredient in aspirin combined with popular diabetes drug can turn off faulty protein that plays a key role in inflammatory diseases, such as rheumatoid arthritis.

Targeting a certain antioxidant protein reduces the aggressiveness of triple-negative breast cancer and increases its sensitivity to conventional anti-cancer drugs.

Two TNF-inhibitors found equally effective treating RA patients.

Targeted personalized therapy in patients with diabetes can reduce the risk of developing cancer.

Surprising findings from a study revealed that losing weight may not help protect against liver and colon cancer.

Stability of exhausted T cells in mice effects the durability of reinvigoration by PD-1 blockade.

Top news of the day from across the health care landscape.

Researchers able to predict treatment response to TNFI drugs and rituximab in RA patients.

Top news of the day from across the health care landscape.

John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how specialty stakeholders can accurately encapsulate the high volume of data they produce to improve operations.

Top news of the day from across the health care landscape.

Two existing drugs, Gemcitabine and DON, target the degradation of nucleotides in the liver.

Promising data on pediatric relapsed/refractory acute lymphoblastic leukemia to be presented.

Researchers have identified an antibody that can neutralize 98% of HIV strains, and may serve as a potential candidate for future HIV treatment and prevention.

Potent antibody may prove more advantageous for HIV prevention and treatment strategies.

Cognitive and physical fitness may play a role in the development of ALS.

Targeting TAZ can essentially stop fibrosis and may provide future treatment options for patients with nonalcoholic steatohepatitis.

Top news of the day from across the health care landscape.

Viral loads were reduced in SIV-infected rhesus monkeys given an experimental vaccine in combination with an immune stimulant.

A simple questionnaire and testing can help identify more patients with chronic obstructive pulmonary disease.

Top news of the day from across the health care landscape.

Baricitinib significantly improved patient-reported outcomes in individuals with RA.

Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses the implications of the Medicare Home Infusion Site of Care Act for specialty pharmacy stakeholders.

Combination immunotherapy more successful in treating advanced skin cancer.

A post-hoc analysis of a pair of phase 3 trials evaluating baricitinib in patients with rheumatoid arthritis (RA) showed significant improvement in patient-reported outcomes compared with placebo and adalimumab (Humira).

Baricitinib is a once-daily oral selective JAK1 and JAK2 inhibitor for the treatment of autoimmune and inflammatory diseases.

Two pilot studies are transplanting infected kidneys into patients and then treating them with curative hepatitis C medications.

Top news of the day from across the health care landscape.

Zepatier shows promise across genotypes 1 and 4, even among patients administered opioid agonist therapy.